Axsome Therapeutics (AXSM) Treasury Shares (2020 - 2026)

Axsome Therapeutics has disclosed Treasury Shares across 7 years of filings, most recently posting $64281.0 for Q1 2026.

• Treasury Shares for Q1 2026 came in at $64281.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $64281.0 (changed 0.0% YoY), and the FY2025 annual result was $1.0 million, up 11.67% from the prior year.
• Treasury Shares came in at $64281.0 for Q1 2026 at Axsome Therapeutics, down from $1.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.0 million in Q4 2025 to a low of $64281.0 in Q1 2025.
• The 5-year median for Treasury Shares is $776708.0 (2023), against an average of $636007.2.
• Across the five-year window, Treasury Shares surged 130.75% in 2022 and tumbled 93.03% in 2025, its largest moves.
• Axsome Therapeutics' Treasury Shares stood at $686375.0 in 2022, then increased by 17.16% to $804150.0 in 2023, then rose by 12.78% to $906944.0 in 2024, then gained by 11.67% to $1.0 million in 2025, then tumbled by 93.65% to $64281.0 in 2026.
• The last three Treasury Shares figures came in at $64281.0 (Q1 2026), $1.0 million (Q4 2025), and $64281.0 (Q3 2025), per Business Quant data.